Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Structure-guided intrinsic stabilization enhances apparent systemic persistence of thymosin α1 while preserving immunomodulatory function.

Created on 18 Nov 2026

Authors

Xuan Xia, Junming Tan, Shuhong Zhang, Tanyuxuan Yang, Xiaojuan Chen, Jianyan Qin, Reza Yousefi, Yongheng Chen

Published in

Biochemical pharmacology. Pages 118662. Nov 17, 2026. Epub Nov 17, 2026.

Abstract

Short therapeutic peptides are often limited by rapid systemic clearance and insufficient in vivo persistence. Although formulation- and carrier-based approaches can improve delivery, intrinsic sequence optimization remains underexplored. Using thymosin α1 (Tα-1) as a clinically validated model, we applied structure-guided intrinsic stabilization to improve apparent systemic persistence while preserving context-dependent immunomodulatory function. An AlphaFold-derived comparative scaffold, FoldX single-site scanning, and DUET cross-validation identified D15 and E27 as stability-permissive engineering sites. D15M showed the most consistent overall improvement, whereas E27R supported E27 as a second optimization site. Both variants retained native-like structural features, resisted serum-associated degradation, and showed prolonged apparent systemic persistence after both subcutaneous and intravenous administration. These gains were accompanied by preserved biological activity in immunosuppressed mice, a tumor xenograft model, murine and human macrophage systems, and donor-derived peripheral blood mononuclear cells. The optimized variants maintained the context-dependent immunomodulatory profile of native Tα-1 rather than producing a broad constitutive increase in intrinsic activity. These findings support structure-guided intrinsic stabilization as a complementary strategy for improving the developability and systemic performance of short therapeutic peptides without compromising biological function.

PMID:
43044988
Bibliographic data and abstract were imported from PubMed on 18 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement